Real-Life Effectiveness and Tolerability of Perampanel in Pediatric Patients Aged 4 Years or Older with Epilepsy: A Korean National Multicenter Study

BACKGROUND AND PURPOSE: The US Food and Drug Administration approval for perampanel has only recently been expanded to patients as young as 4 years, and so there have been few real-life studies of the effects of perampanel in pediatric patients. The aim of this study was to determine the long-term e...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Su-Kyeong, Lee, Yun-Jin, Nam, Sang Ook, Kim, Won Seop, Kim, Jon Soo, Kim, Sun Jun, Lee, Yun-Jeong, Kwon, Soonhak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974830/
https://www.ncbi.nlm.nih.gov/pubmed/31942758
http://dx.doi.org/10.3988/jcn.2020.16.1.53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974830/
https://www.ncbi.nlm.nih.gov/pubmed/31942758
http://dx.doi.org/10.3988/jcn.2020.16.1.53

Ejemplares similares